Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-05-18 Tax Withholding | 2022-05-20 4:28 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | deVries Tina Marie EVP, Research & Development | 5,447 | $1.4 | 136,141 (Direct) | View |
2022-01-24 Tax Withholding | 2022-01-26 4:31 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | deVries Tina Marie EVP, Research & Development | 9,607 | $1.13 | 141,588 (Direct) | View |
2021-11-04 Option Award | 2021-11-08 4:09 pm | N/A 2031-11-04 | Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie EVP, Research & Development | 216,944 | $0 | 216,944 (Direct) | View |
2021-05-18 Tax Withholding | 2021-05-20 4:05 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie EVP, Research & Development | 6,467 | $3.12 | 151,195 (Direct) | View |
2021-01-24 Tax Withholding | 2021-01-26 7:01 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie EVP, Research & Development | 9,597 | $4.46 | 157,662 (Direct) | View |
2020-05-18 Option Award | 2020-05-20 9:48 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie EVP, Research & Development | 71,550 | $0 | 238,809 (Direct) | View |
2020-01-28 Tax Withholding | 2020-01-30 5:38 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie EVP, Research & Development | 9,140 | $7 | 95,709 (Direct) | View |